Talk:2023 Project 7

References

1. Vega-Lopez GA, Cerrizuela S, Tribulo C, Aybar MJ. Neurocristopathies: New insights 150 years after the neural crest discovery. Dev Biol. 2018;444 Suppl 1:S110-S43. PMID: 29802835

2. Sato TS, Handa A, Priya S, Watal P, Becker RM, Sato Y. Neurocristopathies: Enigmatic Appearances of Neural Crest Cell-derived Abnormalities. Radiographics. 2019;39(7):2085-102. PMID: 31697622

3. Goos JAC, Mathijssen IMJ. Genetic Causes of Craniosynostosis: An Update. Mol Syndromol. 2019;10(1-2):6-23. PMID: 30976276 Review.

4. Usman N, Sur M. CHARGE Syndrome. StatPearls. Treasure Island (FL)2021. PMID: 32644625

5. Lackey AE, Muzio MR. DiGeorge Syndrome. StatPearls. Treasure Island (FL)2021. PMID: 31747205

6. Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005-11. PMID: 25398793 Review.

7. Wulf AM, Moreno MM, Paka C, Rampasekova A, Liu KJ. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer. Int J Mol Sci. 2021;22(21). PMID: 34769149

8. Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31(4):391-406. PMID: 20127975 Review

9. Huang S, Song J, He C, Cai X, Yuan K, Mei L, et al. Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome. Gene Ther. 2022;29(9):479-97. PMID: 33633356